← The Wire
BDSXNasdaq
BIODESIX INC
Services-Medical Laboratories · DE · CIK 1439725
Biodesix provides diagnostic testing services for lung disease and COVID-19, and develops companion diagnostics for biopharmaceutical companies
$156M
Market cap
$23.81
Last close
+2.0%
1D
+37.2%
5D
161K
Volume
Price · last 39 sessions+111.3%
May 4L $11.27 · H $23.81Jun 29
114
Total filings
May 20, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteMay 20, 202610-Q10-QMay 4, 20268-KResults of OperationsMay 4, 2026DEFA14ADEFA14AApr 9, 2026DEF 14ADEF 14AApr 9, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 2026SC 13D/ASC 13D/AJan 27, 20268-K/AResults of OperationsJan 12, 202610-Q10-QNov 3, 20258-KResults of OperationsNov 3, 20258-KCompany UpdateOct 1, 20258-KSecurity-Holder Rights · Bylaw AmendmentSep 15, 20258-KCompany UpdateSep 11, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KShareholder VoteMay 21, 202510-Q10-QMay 13, 20258-KResults of OperationsMay 13, 2025DEF 14ADEF 14AApr 28, 20258-KExecutive ChangeApr 17, 20258-KDelisting NoticeMar 28, 202510-K10-KMar 3, 20258-KResults of OperationsMar 3, 20258-KResults of OperationsJan 10, 2025424B5424B5Nov 12, 202410-Q10-QNov 1, 20248-KResults of OperationsNov 1, 20248-KReg FD DisclosureAug 15, 2024424B5424B5Aug 7, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 2024SC 13GFORM 13G BIODESIXJun 24, 2024S-1/AS-1/AMay 24, 20248-KShareholder VoteMay 23, 2024SC 13GSC 13GMay 13, 202410-Q10-QMay 8, 20248-KResults of OperationsMay 8, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 2024S-1S-1Apr 23, 20248-KMaterial Agreement · Equity IssuanceApr 9, 2024424B5424B5Apr 5, 2024424B5424B5Apr 5, 202410-K10-KMar 1, 20248-KResults of OperationsMar 1, 20248-KNew Debt / ObligationDec 20, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 202310-Q10-QAug 7, 20238-KResults of OperationsAug 7, 20238-KCompany UpdateJul 26, 20238-KExecutive ChangeJun 6, 20238-KShareholder VoteMay 25, 20238-KResults of OperationsMay 11, 202310-Q10-QMay 11, 2023DEFA14ADEFA14AApr 12, 2023DEF 14ADEF 14AApr 12, 2023SC 13GSC 13GMar 21, 202310-K10-KMar 6, 20238-KResults of OperationsMar 6, 2023SC 13DSC 13DJan 13, 20238-KExecutive Change · Reg FD DisclosureDec 16, 2022SC 13DSC 13DDec 1, 20228-KMaterial Agreement · Agreement TerminatedNov 21, 2022424B5424B5Nov 18, 2022424B5424B5Nov 16, 202210-Q10-QNov 3, 20228-KResults of OperationsNov 3, 20228-KResults of OperationsOct 11, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 20228-KShareholder VoteMay 25, 202210-Q10-QMay 11, 20228-KResults of OperationsMay 11, 2022SC 13DSC 13DApr 18, 20228-KMaterial Agreement · Equity IssuanceApr 11, 2022DEFA14ADEFA14AMar 31, 2022DEF 14ADEF 14AMar 31, 202210-K10-KMar 14, 2022
Insider Activity
In the 90 days to Feb 23, 2026: 1 insider bought $2.1M · 5 sold $116K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 23, 2026 | Hutton ScottPresident & CEO | Sell | 1,490 | $12.78 | $19K |
| Feb 23, 2026 | Pestano Gary AnthonyChief Development Officer | Sell | 556 | $12.78 | $7K |
| Feb 23, 2026 | O'Kane KieranChief Commercial Officer | Sell | 535 | $12.78 | $7K |
| Feb 23, 2026 | Cowie Robin HarperCFO, Sec'y & Treasurer | Sell | 535 | $12.78 | $7K |
| Feb 23, 2026 | Vazquez ChrisChief Accounting Officer | Sell | 211 | $12.78 | $3K |
| Feb 10, 2026 | Hutton ScottPresident & CEO | Sell | 3,559 | $10.08 | $36K |
| Feb 10, 2026 | Cowie Robin HarperCFO, Sec'y & Treasurer | Sell | 941 | $10.08 | $9K |
| Feb 10, 2026 | O'Kane KieranChief Commercial Officer | Sell | 584 | $10.08 | $6K |
| Feb 10, 2026 | Pestano Gary AnthonyChief Development Officer | Sell | 540 | $10.08 | $5K |
| Feb 10, 2026 | Vazquez ChrisChief Accounting Officer | Sell | 101 | $10.08 | $1K |
| Jan 26, 2026 | Schuler Jack WTenPercentOwner,Other | Buy | 20,000 | $11.80 | $236K |
| Jan 23, 2026 | Schuler Jack WTenPercentOwner,Other | Buy | 80,000 | $11.81 | $945K |
| Jan 22, 2026 | Schuler Jack WTenPercentOwner,Other | Buy | 82,465 | $10.96 | $904K |
| Jan 16, 2026 | Hutton ScottPresident & CEO | Sell | 970 | $8.15 | $8K |
| Jan 16, 2026 | Cowie Robin HarperCFO, Sec'y & Treasurer | Sell | 298 | $8.15 | $2K |
| Jan 16, 2026 | Pestano Gary AnthonyChief Development Officer | Sell | 298 | $8.15 | $2K |
| Jan 16, 2026 | O'Kane KieranChief Commercial Officer | Sell | 298 | $8.15 | $2K |
| Jan 16, 2026 | Vazquez ChrisChief Accounting Officer | Sell | 83 | $8.15 | $676 |
| Nov 10, 2025 | Hutton ScottPresident & CEO | Sell | 189 | $7.62 | $1K |
| Nov 10, 2025 | Cowie Robin HarperCFO, Sec'y & Treasurer | Sell | 50 | $7.62 | $381 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance